November 24, 2008 at 6:01 am | Steroids and Football, Steroids in Sports
- Posted by Millard Baker |
The Canadian Football League (CFL) is the only professional sporting league in North America that has not yet implemented steroid testing for its football players. Former WADA chief Dick Pound had previously called the CFL a “summer camp” for NFL players suspended for violations of the NFL policy on anabolic steroids and related substances (“WADA chief Pounds on CFL,” October 19, 2006).
“We’ve got the CFL,” Pound said. “It’s like a bad scene from the NHL. They say, ‘We don’t test in the Canadian Football League because we don’t need to test — there’s no drug use.’ Helloooo. We’re like a refuge for all the Americans… a summer camp for NFL players who have been suspended for drug use.”
This weekend, John Fahey, the head of the World Anti-Doping Agency (WADA), publicly urged the CFL to adopt an anti-doping testing program. Fahey was in Montreal for the World Anti-Doping Agency (WADA) Executive Committee and Foundation Board meeting. Fahey made his comments just prior to the 2008 CFL Grey Cup Final between the Calgary Stampeders and the Montreal Alouettes Read the rest of this entry
November 19, 2008 at 2:59 pm | Steroids and Football
- Posted by Millard Baker |
The National Football League apparently is willing to jeopardize the health of its players in a misguided effort to catch athletes who use banned performance enhancing subtances. John Lombardo, M.D., the administrator and medical advisor to the NFL Policy regarding Anabolic Steroids and Related Substances allegedly knew that the dietary supplement StarCaps were contaminated with bumetanide as early as 2006. Bumetanide is a powerful prescription diuretic found in StarCaps but not disclosed by the manufacturer. Yet, he failed to notify any NFL teams about the discovery to prevent athletes from using StarCaps as an explanation for a positive bumetanide test result exposing NFL players to significant health risks that could have easily been prevented by responsible concern for players’ health and well-being as the primary objective.
Attorney David Cornwell, representing New Orleans Saints Deuce McAllister, Charles Grant, and Will Smith, made this allegation the NFL appeals hearing regarding the four-game suspensions resulting from bumetanide-positive drug tests (“Cornwell Says NFL Failed to Warn Players That StarCaps Contains Bumetanide,” November 19).
Cornwell contends that Dr. John Lombardo, the administrator of the NFL’s policy regarding anabolic steroids and related substances, testified during the hearing that he learned in late 2006 of the presence of Bumetanide in StarCaps. Lombardo, per Cornwell, did not share this information with NFL players, because Lombardo feared that other players testing positive for Bumetanide would claim that they were taking StarCaps, even if they weren’t.
Says Cornwell: “Dr. Lombardo’s failure to disclose what he knew about StarCaps may have exposed NFL players to the significant health risks associated with the unintentional ingestion of diuretics. If Dr. Lombardo had notified NFL players that StarCaps contained bumetanide, Will, Deuce and Charles would have never used the product to lose weight.”
John Lombardo has previously notified teams of supplements that may cause NFL players to fail a drug test even when the banned substance was fully disclosed on the product labels. Why did he not notify players about the great threat of an UNDISCLOSED prescription drug in supplements that may have been used by NFL players!?! Read the rest of this entry
November 12, 2008 at 2:41 am | Steroids in Sports
- Posted by Millard Baker |
The 2008 Growth Hormone Summit was held by the David Geffen School of Medicine at UCLA in conjunction with Major League Baseball (MLB) and the law firm of Foley and Lardner at the Beverly Hills Hotel in California on November 10, 2008. Dr. Gary Green, professor of family medicine at the UCLA medical school, chaired the conference of leading anti-doping experts and scholars. “Growth Hormone: Barriers to Implementation of hGH in Sports” addressed several scientific, legal and ethical issues involving testing athletes for human growth hormone (“Landmark conference to look at use of human growth hormone by athletes,” October 22).
- understanding the currently available methods for identifying use of hGH and understanding the viability of urine testing for hGH in the future;
- building a consensus on the most effective methods of implementing widespread blood testing for abuse of hGH;
- identifying future strategies for hGH testing; and
- understanding the United States Laws regarding the regulation and distribution of hGH
The current state of HGH testing involves blood testing. Anti-doping expert Don Catlin supervised growth hormone testing at the 2008 Beijing Olympics which involved approximately 1,000 blood samples; no athlete tested positive for HGH. In fact, no athlete has ever tested positive for human growth hormone using this test which has led many experts to question the effectiveness of the test (“Officials Question a Blood Test That Is Never Positive,” November 10)
Three hours into a conference held Monday by Major League Baseball on human growth hormone, the real question of the day emerged when officials from the commissioner’s office and the players union wondered aloud about how effective the current blood test for human growth hormone was if no one had tested positive.
[...]
Osquel Barroso, the senior manager of science for the World Anti-Doping Agency, was one such expert invited to the conference. WADA, which oversees the testing of Olympic athletes, has tested 8,500 athletes for human growth hormone since 2000 and has never had a test come back positive.
The big news at the Growth Hormone Summit was the increasingly viable urine test for human growth hormone that utilizes nanotechnology to identify urinary HGH markers. Don Catlin, CEO of Anti-Doping Research and Professor Emeritus at the UCLA School of Medicine is collaborating with Lance Liotta, MD, PhD of George Mason University to validate the utility of this test for WADA Read the rest of this entry
